Q6X-23141-43621
3 vaccinations
5 coded responses
25 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 601 / IL
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 1 — Pfizer-BioNTech
-
2021-03-10
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-12
- 2021-03-13
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-24
-
2021-03-31
Dose 2 — Pfizer-BioNTech
- 2021-04-23
- 2021-05-05
- 2021-05-12
-
2021-11-24
Dose 3 — Pfizer-BioNTech
-
2021-11-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-11-30
-
2021-12-01
Survey response — day 7, dose 3MedDRA: Headache — Feeling: Good · HeadacheFree text: Morning headacheMedDRA releases: 2024-11 · check-in free text available
- 2021-12-08
- 2021-12-15
-
2021-12-24
Survey response — day 28, dose 3MedDRA: Cough, Sneezing — Feeling: FairFree text: Cough sneezeMedDRA releases: 2024-11 · check-in free text available
- 2021-12-30
-
2022-02-25
Survey response — 3 months, dose 3MedDRA: Cough — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Chronic coughMedDRA releases: 2024-11 · check-in free text available
-
2022-11-24
Survey response — 12 months, dose 3MedDRA: Influenza — Feeling: Poor · Be unable to work or attend schoolFree text: FluMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Pfizer-BioNTech | |
| 2 | 2021-03-31 | Pfizer-BioNTech | |
| 3 | 2021-11-24 | Pfizer-BioNTech | No |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): No
Release 10 — day 7, dose 3
Systemic reaction (other): Morning headache
Release 10 — day 28, dose 3
Symptoms: Cough sneeze
Release 11 — 3 months, dose 3
Symptoms: Chronic cough
Release 12 — 12 months, dose 3
Symptoms: Flu
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release